SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-13-000374
Filing Date
2013-08-14
Accepted
2013-08-14 17:29:08
Documents
10
Period of Report
2013-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ptla-10q_20130630.htm 10-Q 1727551
2 EX-31.1 ptla-ex31_201306296.htm EX-31 17644
3 EX-31.2 ptla-ex31_201306297.htm EX-31 17492
4 EX-32.1 ptla-ex32_201306298.htm EX-32 9511
  Complete submission text file 0001564590-13-000374.txt   12534179

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ptla-20130630.xml EX-101.INS 1760384
6 XBRL TAXONOMY EXTENSION SCHEMA ptla-20130630.xsd EX-101.SCH 41694
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ptla-20130630_cal.xml EX-101.CAL 38656
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ptla-20130630_def.xml EX-101.DEF 235197
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptla-20130630_lab.xml EX-101.LAB 309951
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptla-20130630_pre.xml EX-101.PRE 280971
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Filer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35935 | Film No.: 131037970
SIC: 2834 Pharmaceutical Preparations